TWP
LEGN icon

Tempus Wealth Planning’s Legend Biotech LEGN Stock Holding History

Tempus Wealth Planning’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,217
Closed -$266K – 282
2025
Q4 		$266K Buy
12,217
+4,141
+51% +$119K 0.06% 242
2025
Q3 		$263K Buy
+8,076
New +$298K 0.06% 242

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Tempus Wealth Planning's LEGN Position: Q1 2026 in Review

Tempus Wealth Planning sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 12,217 shares — an estimated $266K sold.

Tempus Wealth Planning first reported a position in LEGN in Q3 2025 and held it in 2 quarters. The position peaked at $266K in Q4 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Tempus Wealth Planning reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Tempus Wealth Planning sold 12,217 Legend Biotech shares in Q1 2026, an estimated $266K.
  • Tempus Wealth Planning first reported a position in Legend Biotech in Q3 2025 and held it in 2 quarters.
  • Tempus Wealth Planning's Legend Biotech position peaked at $266K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Tempus Wealth Planning's 13F filing for Q1 2026, filed 29 Apr 2026.